Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
COVID-19 Impact on Global Oncology Drugs Market By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer and Other Cancers); By Type (Chemotherapy, Targeted Therapy, Immunotherapy and Hormonal Therapy) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030
... Targeted Therapy, Immunotherapy and Hormonal Therapy) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030 COVID-19 Impact on Global Oncology Drugs Market By Indication (Lung Cancer, Stomach ... Read More
-
Personalized Cell Therapy Market, By Cell Type (Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, and Others), by Therapeutic Area (Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, and Cancer), and by Region (No
... Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 The patient-tailored therapies for the treatment of various diseases is known as personalized cell therapy. The personalized cell ... Read More
-
Medical Device Regulatory Affairs Market By Services (Regulatory consulting /Strategic Services, Regulatory writing and publishing, Legal representation, Product Registration and Clinical trials, Others), By Service Provider (In-House, Out sourcing), By Types (Diagnostic, Therapeutics), By Indication (Infectious Diseases, Oncology and Hematology, Gynaecology and Obstetrics, Muscusloskeletal Disorders, Respiratory, Cardiovascular, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... (Infectious Diseases, Oncology and Hematology, Gynaecology and Obstetrics, Muscusloskeletal Disorders, Respiratory, Cardiovascular, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global Medical Device Regulatory Affairs Market was valued at $6,969.7 million in 2021, and ... Read More
-
North America Outbound Medical Tourism Services Market, By Therapeutic Application (Cosmetic Surgery Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedic Treatment, Cancer Treatment, Fertility Treatment, Weight Loss Treatment, Spinal Surgery
... By Countries (U.S., Canada) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Outbound medical tourism is defined as traveling of patients outside their country to avail various medical treatments. The preferred countries by ... Read More
-
Global Cancer Diagnostics Market Size study, by Diagnostic Type (Diagnostic Imaging, Tests, Biopsy and Cytology Tests, Tumour Biomarkers and Other Diagnostic Types) by Application (Breast Cancer, Lung Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer and Other Applications) and Regional Forecasts 2022-2028
... Cancer, Ovarian Cancer and Other Applications) and Regional Forecasts 2022-2028 Global Cancer Diagnostics Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Exosome Research Products Market Size study, by Application (Cancer Applications, Non-Cancer Applications), by Products & Services (Kits and Reagents, Instruments, Services), by End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories) and Regional Forecasts 2022-2028
... Testing Laboratories) and Regional Forecasts 2022-2028 Global Exosome Research Products Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % ... Read More
-
2022 Global: Oncology Nutrition - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
Anal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Anal Cancer (Oncology) pipeline landscape. Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of ... Read More
-
B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline landscape. B-Cell Chronic Lymphocytic Leukemia is a type of slow growing leukemia that affects developing B-lymphocytes (also known as B-cells). ... Read More
-
Acute Myeloid Leukemia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... therapeutics. Synopsis In 2022, there will be more than 156,000 diagnosed prevalent cases of acute myeloid leukemia across 16 pharmaceutical markets. There are 10 leading marketed drugs for the treatment of acute myeloid leukemia, Bristol ... Read More
-
Synovial Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Synovial Sarcoma (Oncology) pipeline landscape. Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or spindle cell components. Symptoms include swelling, ... Read More
-
Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Osteosarcoma (Oncology) pipeline landscape. Osteosarcoma is the most common cancer of the bone that destroys tissue and weakens the bone. It is developed from immature bone cells that normally form new bone ... Read More
-
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... In Development, 2022, provides an overview of the Hodgkin Lymphoma (Oncology) pipeline landscape. Hodgkin lymphoma is a cancer that starts in white blood cells called lymphocytes. Symptoms include painless swelling of the lymph nodes in ... Read More
-
Rectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are ... Read More
-
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer, Urothelial/Bladder Cancer), By Technology (Cleavable, Non-cleavable Linker, Linkerless), And Segment Forecasts, 2022 - 2030
... size is expected to reach over USD 22.87 billion by 2030, registering a CAGR of 16.4% during the forecast period, according to a new report by Grand View Research Inc. The presence of strong pipeline ... Read More
-
Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Nasopharyngeal Cancer (Oncology) pipeline landscape. Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of throat, behind the nose. This area is ... Read More
-
Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication (Pain Management, Oncology, CNS Condition, Diabetes, Obesity), By Region, And Segment Forecasts, 2022 - 2030
... by Grand View Research, Inc. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed ... Read More
-
Clinical Trials Site Management Organizations Market Size, Share & Trends Analysis Report By Clinical Trail Services/Components, By Phase, By Therapeutic Areas (Oncology, Cardiology, CNS), By Region, And Segment Forecasts, 2022 - 2030
... Research, Inc. The market is expected to expand at a CAGR of 6.1% from 2022 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the ... Read More
-
Global Synthetic Stem Cells Market Size study, by Application (Cardiovascular Disease, Neurological Disorders, Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorder), By End-Use (Hospitals And Surgical Centers, Academic Institutes, Research Laboratories, Pharmaceutical And Biotechnology Companies, Others) and Regional Forecasts 2022-2028
... Forecasts 2022-2028 Global Synthetic Stem Cells Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period ... Read More
-
Global Molecular Cytogenetics Market Size study, by Product (Kits & Reagents, Instruments, Consumables, Software & Services), by Application (Genetic Disorders, Cancer, Personalized Medicine, Other Applications), by End-use (Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Other End-users) and Regional Forecasts 2022-2028
... and Biotechnology Companies, Other End-users) and Regional Forecasts 2022-2028 Global Molecular Cytogenetics Market is valued at approximately USD 2.5 billion in 2021 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Omics-Based Clinical Trials Market Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028
... CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028 Global Omics-Based Clinical Trials Market is valued at approximately USD 24.4 billion in 2021 and is anticipated ... Read More
-
Global Long-acting Monoclonal Antibodies Market Size Study, By Source Type (Murine, Chimeric, Humanized, Human) By Indication (Cancer, Autoimmune Disease, Inflammatory Disease, Infectious Disease, Others) By End-User (Hospital Pharmacies, Drug Store, Retail Pharmacies, E-Commerce) and regional forecasts 2022-2028
... forecasts 2022-2028 Global Long-acting Monoclonal Antibodies Market is valued approximately USD xx Billion in 2021 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2022-2028. ... Read More
-
2022 Global Forecast for Lung Cancer Surgery (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Pancreatic Cancer Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... expected to reach USD 5,656.58 million by 2027, registering a CAGR of 7.43% from 2022 to 2027. The outbreak of COVID-19 significantly reduced hospital and healthcare services, impacting the pancreatic cancer therapeutics and diagnostics market. ... Read More
Research Assistance
